|
AF and Liraglutide
(n= )
|
AF and no Liraglutide
(n = )
|
P-Value
|
AF and Liraglutide
(n = )
|
AF and no Liraglutide
(n = )
|
P-Value
|
Age (years) at Dx of AF (mean + SD) |
65.4
+ 10.6 |
71.3 + 12.8 |
< 0.0001 |
65.5 +
10.5 |
65 + 13.4 |
< 0.0001 |
Gender |
Gender |
Gender |
Gender |
Gender |
Gender |
Gender |
Male |
57.5% |
56.6% |
0.0202 |
57.5% |
58.9% |
0.0093 |
Female |
45.5% |
43.4% |
0.0208 |
42.5% |
41.1% |
0.0087 |
Unknown |
18.7% |
26.2% |
< 0.0001 |
18.8% |
18.5% |
0.4757 |
Race/Ethnicity |
Race/Ethnicity |
Race/Ethnicity |
Race/Ethnicity |
Race/Ethnicity |
Race/Ethnicity |
Race/Ethnicity |
White |
78.8% |
79.8% |
< 0.0001 |
78.8% |
79.6% |
0.1325 |
Black |
12.6% |
9.2% |
< 0.0001 |
12.6% |
11.8% |
0.0221 |
Asian |
0.7% |
1.3% |
< 0.0001 |
0.7% |
0.6% |
0.3436 |
Hispanic/Latino |
4.7% |
2.9% |
< 0.0001 |
4.7% |
4.3% |
0.0960 |
Co-Morbidities |
Co-Morbidities |
Co-Morbidities |
Co-Morbidities |
Co-Morbidities |
Co-Morbidities |
Co-Morbidities |
HTN |
81.6% |
44.2% |
< 0.0001 |
81.6% |
79.9% |
0.0001 |
Ischemic Heart Disease |
48.3% |
23.1% |
< 0.0001 |
48.2% |
46.9% |
0.0190 |
Heart Failure |
36.8% |
15.4% |
< 0.0001 |
36.8% |
35.3% |
0.0051 |
Metabolic Diseases |
78.5% |
40.2% |
< 0.0001 |
78.5% |
77.2% |
0.0064 |
Nonrheumatic Mitral Valvular Disease |
16.2% |
9.1% |
<
0.0001 |
16.2% |
15.3% |
0.0261 |
Nonrheumatic Aortic Valve Disease |
12.2% |
7.7% |
< 0.0001 |
12.2% |
11.3% |
0.0113 |
Chronic Rheumatic Heart Disease |
10.8% |
5.9% |
< 0.0001 |
10.8% |
9.5% |
0.0002 |
Type 2 Diabetes Mellitus |
81.2% |
18.3% |
< 0.0001 |
81.1% |
81.3% |
0.6906 |
Cerebrovascular Disease |
20.8% |
12.1% |
< 0.0001 |
20.8% |
19.8% |
0.0263 |
Vascular Disease |
27.3% |
13.8% |
< 0.0001 |
27.3% |
26.1% |
0.0139 |
Renal and Genitourinary Disease |
64.1% |
33.0% |
< 0.0001 |
64.0% |
62.7% |
0.0145 |
Respiratory Disease |
60.6% |
32.5% |
< 0.0001 |
60.5% |
58.9% |
0.0030 |
Neoplasms |
37.5% |
22.3% |
< 0.0001 |
37.5% |
37.0% |
0.3643 |
Others |
Others |
Others |
Others |
Others |
Others |
Others |
Cardiovascular Procedures |
68.6% |
40.4% |
< 0.0001 |
68.5% |
66.7% |
0.0004 |
Cardiovascular Medications |
92.7% |
57.7% |
< 0.0001 |
92.7% |
93.0% |
0.2359 |
Blood Glucose Lowering Agents |
89.5% |
24.0% |
< 0.0001 |
89.5% |
91.3% |
< 0.0001 |